3 Lessons from a Multi Billion Dollar Loss in $VRX

As you probably know, Bill Ackman is the founder and CEO of the hedge fund, Pershing Square Capital Management. Last week, he gained a lot of press coverage for one particularly bad investment in Valeant Pharmaceuticals (VRX). By his own admission, the Valeant investment was “one very big mistake.” That might be the understatement of … Read More